HomeCompareESRCF vs PFE

ESRCF vs PFE: Dividend Comparison 2026

ESRCF yields 1.99% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ESRCF wins by $61.5K in total portfolio value
10 years
ESRCF
ESRCF
● Live price
1.99%
Share price
$1.51
Annual div
$0.03
5Y div CAGR
50.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$111.1K
Annual income
$41,739.49
Full ESRCF calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — ESRCF vs PFE

📍 ESRCF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodESRCFPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ESRCF + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ESRCF pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ESRCF
Annual income on $10K today (after 15% tax)
$168.87/yr
After 10yr DRIP, annual income (after tax)
$35,478.57/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, ESRCF beats the other by $13,158.66/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ESRCF + PFE for your $10,000?

ESRCF: 50%PFE: 50%
100% PFE50/50100% ESRCF
Portfolio after 10yr
$80.3K
Annual income
$33,999.11/yr
Blended yield
42.33%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

ESRCF
No analyst data
Altman Z
0.9
Piotroski
3/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ESRCF buys
0
PFE buys
0
No recent congressional trades found for ESRCF or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricESRCFPFE
Forward yield1.99%6.13%
Annual dividend / share$0.03$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR50.5%13.2%
Portfolio after 10y$111.1K$49.6K
Annual income after 10y$41,739.49$26,258.71
Total dividends collected$84.1K$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ESRCF vs PFE ($10,000, DRIP)

YearESRCF PortfolioESRCF Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$10,999$299.01$9,153$693.39+$1.8KESRCF
2$12,232$462.58$8,593$849.25+$3.6KESRCF
3$13,811$723.55$8,336$1,066.78+$5.5KESRCF
4$15,927$1,149.14$8,437$1,384.80+$7.5KESRCF
5$18,906$1,863.94$9,013$1,875.40+$9.9KESRCF
6$23,341$3,112.04$10,306$2,680.72+$13.0KESRCF
7$30,380$5,404.13$12,820$4,101.38+$17.6KESRCF
8$42,399$9,893.07$17,673$6,826.70+$24.7KESRCF
9$64,788$19,420.48$27,543$12,591.86+$37.2KESRCF
10$111,062$41,739.49$49,560$26,258.71+$61.5KESRCF

ESRCF vs PFE: Complete Analysis 2026

ESRCFStock

ESR Group Limited, together with its subsidiaries, engages in the logistics real estate development, leasing, and management activities in the Public's Republic of China, Japan, South Korea, Singapore, Australia, and India. It operates through three segments: Investment, Fund Management, and Development. The company develops, constructs, invests in, and sells logistics real estate properties, as well as data centers and commercial assets. It is also involved in the fund management business; and warehousing business. In addition, the company invests in properties, co-investments funds and investment vehicles, public REITs, and other investments. It serves e-commerce companies, 3PL providers, bricks-and-mortar retailers, manufacturers, cold-chain logistics providers, and other enterprises in various industries. The company was formerly known as ESR Cayman Limited and changed its name to ESR Group Limited in June 2022. ESR Group Limited was incorporated in 2011 and is headquartered in Central, Hong Kong.

Full ESRCF Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this ESRCF vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ESRCF vs SCHDESRCF vs JEPIESRCF vs OESRCF vs KOESRCF vs MAINESRCF vs JNJESRCF vs MRKESRCF vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.